THCT · As filed with the SEC
THC Therapeutics income statement, by fiscal year
The statement as THC Therapeutics presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENT OF OPERATIONS · USD, except per-share amounts
| USD, except per-share amounts | FY2024 Year ended Jul 31, 2024 | FY2023 Year ended Jul 31, 2023 | FY2022 Year ended Jul 31, 2022 | FY2021 Year ended Jul 31, 2021 | FY2020 Year ended Jul 31, 2020 | Year ended Jul 31, 2019 Year ended Jul 31, 2019 | FY2013 Year ended Jul 31, 2013 | FY2012 Year ended Jul 31, 2012 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Operating expenses | ||||||||
| Professional Fees | 266,637 | 148,496 | 178,897 | 253,838 | 315,755 | 118,749 | 67,796 | 62,676 |
| Consulting fees | — | — | — | — | — | — | — | 161,543 |
| Cost of Revenue | — | — | — | — | — | — | 277,167 | — |
| Cost of Revenue | — | — | — | — | — | — | 0 | 0 |
| Consulting fees | — | 87,170 | 966,533 | 205,170 | 611,313 | 23,881,090 | — | — |
| Payroll expense | — | — | — | — | 192,563 | 134,713 | — | — |
| Labor and Employee Benefits | 34,543 | 187,749 | 462,317 | 267,975 | — | — | — | — |
| Selling, General and Administrative Expense | — | — | 138,281 | — | — | — | — | — |
| Selling, General and Administrative Expense | 240,795 | 70,497 | — | 212,994 | 178,665 | 99,819 | 19,736 | 16,133 |
| Asset Impairment Charges | — | — | — | — | 0 | 2,429,981 | — | — |
| Depreciation Expense | — | — | — | — | 20,114 | 25,558 | — | — |
| Total operating expenses | 541,975 | 493,912 | 1,746,028 | 939,977 | 1,318,410 | 26,689,910 | 364,699 | 240,352 |
| Loss from operations | (541,975) | (493,912) | (1,746,028) | (939,977) | (1,318,410) | (26,689,910) | (364,699) | (240,352) |
| Other income (expense) | ||||||||
| Non-Operating Income (Expense) | (125,444) | 184,143 | 327,501 | (393,718) | 58,080 | (3,928,049) | — | — |
| Interest Expense | 0 | 2,310 | — | 0 | (165,000) | (37,500) | — | — |
| Loss on sale of investment | — | — | — | 0 | (12,149) | 0 | — | — |
| Gain on recission of token agreements | — | — | — | — | 0 | 7,651,981 | — | — |
| Interest expense | (144,143) | (79,577) | (100,402) | (551,750) | (487,700) | (303,586) | 0 | (1,200) |
| Gain on settlement of accrued expenses | — | — | — | — | — | — | — | 0 |
| TOTAL OTHER INCOME (EXPENSE) | — | — | — | — | — | — | — | (1,200) |
| Interest Expense | — | — | — | — | — | — | (2,082) | — |
| Net Cash from Financing Activities | — | — | — | — | — | — | (2,917) | — |
| Gain on settlement of accrued expenses | — | — | — | — | — | — | 0 | — |
| Interest Expense | — | — | — | — | — | — | (3,403) | — |
| Change in fair market value of derivative liability | — | — | — | — | — | — | (25) | — |
| Loss on issuance of stock | — | — | — | — | — | — | (760,000) | — |
| Other Expense | — | — | — | — | — | — | (768,427) | — |
| LOSS BEFORE PROVISION FOR INCOME TAXES | — | — | — | — | — | — | (1,133,126) | (241,552) |
| Current Income Tax Expense | — | — | — | — | — | — | 0 | 0 |
| Net Income to Common Shareholders | — | — | — | — | — | — | (1,133,126) | — |
| NET LOSS PER SHARE: BASIC AND DILUTED | — | — | — | — | — | — | (0.02) | 0.00 |
| WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED | — | — | — | — | — | — | — | 180,925,012 |
| Weighted Average Shares Outstanding, Diluted | — | — | — | — | — | — | 64,593,426 | — |
| Other Non-Cash Items (CF) | — | — | — | (945,468) | (606,769) | 3,382,846 | — | — |
| Total other income (expense) | — | — | 227,099 | — | — | — | — | — |
| Total other income (expense) | (269,587) | 106,876 | — | — | — | — | — | — |
| Net income (loss) | (811,562) | (387,036) | (1,518,929) | (1,885,445) | (1,925,179) | (23,307,064) | — | (241,552) |
| Basic loss per common share | — | (0.01) | — | — | — | — | — | — |
| Basic weighted average common shares outstanding | — | 32,806,009 | — | — | — | — | — | — |
| Earnings Per Share (Basic) | (0.02) | — | (0.05) | (0.08) | (0.12) | (1.74) | — | — |
| Weighted Average Shares Outstanding | 35,680,396 | — | 33,244,334 | 23,659,514 | 16,551,334 | 13,376,774 | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
Data on this page was fetched . The filing on SEC.gov is the record.